Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria

@inproceedings{Avong2015DoingNH,
  title={Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria},
  author={Yohanna Kamabi Avong and Petros Isaakidis and Sven Gudmund Hinderaker and Rafael Van den Bergh and E Chafouz Ali and Bolajoko Oladunni Obembe and Ernest Ekong and Clement Adebamowo and Nicaise Ndembi and James Okuma and Adeline Ijeoma Osakwe and Olanrewaju Oladimeji and Gabriel Akang and Joshua Olusegun Obasanya and Osman Eltayeb and Aderonke Vivian Agbaje and Alash'le Abimiku and Charles Olalekan Mensah and Patrick Sunday Dakum},
  booktitle={PloS one},
  year={2015}
}
BACKGROUND Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria. METHOD This was a retrospective, observational cohort study, using pharmacovigilance data systematically collected at all MDR-TB treatment centers in Nigeria… CONTINUE READING